Relationship Between Necrosis, Neovascularization, and Lymphocyte Reaction in Histopathological Types of Cervical Cancer
Abstract
Abstract: Cervical cancer is a malignant tumour that grows on the cervix, more than 90% of which are caused by HPV 16 and 18. lymphocytes are one of the immune systems that play a role in immunosurveillance against cancer cells. However, cervical cancer will cause necrosis and activate Hypoxia-Inducible Factor-1 (HIF-1) which plays a role in the formation of neovascularization. Based on histopathological findings, cervical cancer types are classified into squamous cell carcinoma (SCC) and adenocarcinoma (ADC). This study aimed to determine the relationship between necrosis, neovascularization, and lymphocyte reaction in various histopathological types of cervical cancer. This research is observational analysis using medical records and histopathological slides of patients diagnosed with cervical cancer. There were 26 cases of cervical cancer consisting of 16 types of SCC and 12 types of ADC. Based on the highest percentage, more necrosis was found in ADC 81.8% (p-value 0.014), neovascularization in SCC 73.3% (p-value 0.014), and lymphocyte reaction in SCC 86.7% (p-value 0.973). This means that there was a significant relationship between necrosis and lymphocyte reaction in various histopathological types of cervical cancer, however, there is no significant relationship between neovascularization in various histopathological types of cervical cancer.
Keywords
Full Text:
PDFReferences
Arbyn, M., Weiderpass, E., Bruni, L., de Sanjosé, S., Saraiya, M., Ferlay, J., & Bray, F. (2020). Estimates of incidence and mortality of cervical cancer in 2018: a worldwide analysis. The Lancet. Global health, 8(2), e191–e203. https://doi.org/10.1016/S2214-109X(19)30482-6
Yasmon D. (2019).Patogenesis Human Papillomavirus (HPV) pada Kanker Serviks.Evriarti, An. J Biotek Medisiana Indones.8.1:23-32. https://doi.org/10.22435/jbmi.v8i1.2580
ME PRASTIO.(2023). Hubungan antara status pendidikan dengan tingkat pengetahuan deteksi dini kanker serviks pada pegawai Fakultas Kedokteran Universitas Islam Sumatera Utara – Medan.
Nechifor-Boilă, Adela; Cotoi, Ovidiu S.; Cîmpean, Anca; Carașca C. (2019).Prevalence and Histopathological Characteristics of Cervical Cancer and Precursor Lesions in Mureş County: A Retrospective, Cohort Study. 39-40.
Zhang, S., Xu, H., Zhang, L., & Qiao, Y. (2020). Cervical cancer: Epidemiology, risk factors and screening. Chinese journal of cancer research = Chung-kuo yen cheng yen chiu, 32(6), 720–728. https://doi.org/10.21147/j.issn.1000-9604.2020.06.05
Parra-Herran,C. (2021). WHO classification. PathologyOutlines https://www.pathologyoutlines.com/topic/cervixWHO.html
Mac Gregor DP. (2022).Anatomical pathology. Med J Aust.176(1):7. https://www.ncbi.nlm.nih.gov/books/NBK557627/
Alshami, I., Alattas, R. O., Waad A, A., & Anwar A, S. (2023). Role of T cells in cervical cancer. Bioinformation, 19(5), 556–561. https://doi.org/10.6026/97320630019556
Katayama, Y., Uchino, J., Chihara, Y., Tamiya, N., Kaneko, Y., Yamada, T., & Takayama, K. (2019). Tumor Neovascularization and Developments in Therapeutics. Cancers, 11(3), 316. https://doi.org/10.3390/cancers11030316
Fu, L. Q., Du, W. L., Cai, M. H., Yao, J. Y., Zhao, Y. Y., & Mou, X. Z. (2020). The roles of tumor-associated macrophages in tumor angiogenesis and metastasis. Cellular immunology, 353, 104119. https://doi.org/10.1016/j.cellimm.2020.104119
Ngatun, S. Riawati, D. (2019). Hubungan Antara Usia Dengan Deteksi Dini Kanker Serviks Metode Iva. Avicenna J Heal Res. 2(2):104-110. https://jurnal.stikesmus.ac.id/index.php/avicenna/article/view/306/234
Cendrowicz, E., Sas, Z., Bremer, E., & Rygiel, T. P. (2021). The Role of Macrophages in Cancer Development and Therapy. Cancers, 13(8), 1946. https://doi.org/10.3390/cancers13081946
PDQ Cancer Information Summaries. Bethesda (MD): National Cancer Institute (US).2022. Cervical Cancer Treatment: Patient Version. 2022 Mar 1. Available from: https://www.ncbi.nlm.nih.gov/books/NBK65985/
Fowler JR, Maani E V, Jack BW. (2022). Cervical Cancer.1-7. https://www.ncbi.nlm.nih.gov/books/NBK431093/
Mekuria, M., Edosa, K., Endashaw, M., Bala, E. T., Chaka, E. E., Deriba, B. S., & Tesfa, B. (2021). Prevalence of Cervical Cancer and Associated Factors Among Women Attended Cervical Cancer Screening Center at Gahandi Memorial Hospital, Ethiopia. Cancer informatics, 20, 11769351211068431. https://journals.sagepub.com/doi/10.1177/11769351211068431
Sha J, Du J, Yang J, Hu X, Li L. (2021). Changes of serum levels of tumor necrosis factor (TNF-α) and soluble interleukin-2 receptor (SIL 2R) in patients with cervical cancer and their clinical significance. Am J Transl Res.13(6):6599-6604.
Yordanov, A., Kostov, S., Slavchev, S., Strashilov, S., Konsoulova, A., Calleja-Agius, J., Di Fiore, R., Suleiman, S., Kubelac, P., Vlad, C., Achimas-Cadariu, P., & Vasileva-Slaveva, M. (2021). Adenosquamous Carcinoma of the Uterine Cervix - Impact of Histology on Clinical Management. Cancer management and research, 13, 4979–4986. https://doi.org/10.2147/CMAR.S311326
Utami IJ, Indrayanti.(2020). Hubungan antara Cell Death dengan Vaskularisasi dan Reaksi Limfosit Squamous Cell Carcinoma Kanker Serviks. J UMY.1- 15.
Aijaz M, Alam K, Maheshwari V (2021) Evaluation of angiogenesis in cervical cancer using CD34 as a biomarker and its correlation with pathoanatomical features. Ann Cytol Pathol 6(1): 007-011. https://www.medsciencegroup.us/articles/ACP-6-123.php
Manzo-Merino J, Del-Toro-Arreola S, Rocha-Zavaleta L, Peralta-Zaragoza Ó, Jiménez-Lima R, Madrid-Marina V.(2020). Immunology of Cervical Cancer. Rev Invest Clin.72(4):188-197. ). https://doi.org/10.24875/ric.20000057
DOI: https://doi.org/10.30596/bf.v9i2.21947
DOI (PDF): https://doi.org/10.30596/bf.v9i2.21947.g12315
Refbacks
- There are currently no refbacks.
JURNAL BULETIN FARMATERA
Gedung Kampus 1 Universitas Muhammadiyah Sumatera Utara (UMSU) Lantai II, Laboratorium Farmakologi dan Terapi Fakultas Kedokteran UMSU Jalan Gedung Arca No. 53 Medan Sumatera Utara Indonesia, Kode Pos 20217.
Contact (WA): 0812-6208-2844
E-mail: farmatera@umsu.ac.id
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.